Thank you for contacting us! We will be in touch soon! In the meantime, feel free to continue browsing our site.
Events
- CNS Drug Delivery Summit 2023: Biocytogen to Showcase Payload Brain Delivery of Fully Human TFR1 HCAbs | November 30, 2023
- Join us at Cell Bio 2023 by American Society for Cell Biology: Dec 2-6 | November 28, 2023
- $1,000 OFF Any Gene Targeting Project | November 20, 2023
- Check out our poster at 15th Annual PEGS Europe: Nov 14-16 | November 14, 2023
- SITC 2023 Highlights: Biocytogen’s Novel Assets and Products | November 08, 2023
- Join us at the Neuroscience 2023: Nov 11-15 | November 01, 2023
News
- Nov 2023 Newsletter | November 16, 2023
- SITC 2023 Highlights: Biocytogen’s Novel Assets and Products | November 08, 2023
- Biocytogen/Eucure Biopharma to Present Complete Clinical Data from YH003 (anti- CD40 mAb) Phase I Trial at ESMO 2023 | October 16, 2023
- Biocytogen Officially Launches RenMice® Series | September 15, 2023
- Biocytogen Enters into Antibody Evaluation, Option and License Agreement with Myricx for ADC Development | September 07, 2023
- Biocytogen Establishes Two Business Divisions to Distinguish Preclinical Models and Services (BioMice) From Antibody Drug R&D | August 30, 2023
